Skip to Content

Join the 'Alpha-1 Proteinase Inhibitor Deficiency' group to help and get support from people like you.

Alpha-1 Proteinase Inhibitor Deficiency News

Related terms: Alpha-1 Antitrypsin Deficiency

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't unexpected, noting that "the declines in the COPD-related mortality are consistent with declines in the prevalence of current smoking for men and women in the United States." But, Ni added, the study only quantified death rate trends, and didn't look at the reasons behind those trends. Ni is an associate director for science with the CDC's division of vital statistics at the U.S. National Center for Health Statistics. Dr. David Mannino, who's with the University of Kentucky's College of Public ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Ventolin, Ribavirin, Qvar, Epinephrine, Flovent, Budesonide, Xopenex, Ipratropium, Entocort, ProAir HFA, Tobramycin, Mometasone, EpiPen, Atrovent, Proventil

Depression Plagues Many With COPD

Posted 17 Jun 2016 by Drugs.com

FRIDAY, June 17, 2016 – Struggling with chronic obstructive pulmonary disorder (COPD) may raise the risk of depression among patients with the incurable respiratory illness, two new studies suggest. One report, from scientists at Manchester Metropolitan University in England, found one in four patients with COPD suffered persistent depressive symptoms over the three years of the study. If untreated, depression can have a negative effect on the patients' overall health and the effectiveness of their treatment, the researchers noted. A second study from the University of Texas analyzed data from a random sample of 5 percent of Medicare beneficiaries diagnosed with COPD between 2001 and 2011. The researchers found that 22 percent of those patients had one or more psychological disorders. The study also showed that the odds of 30-day readmission to the hospital were higher in patients with ... Read more

Related support groups: Depression, Major Depressive Disorder, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Fluticasone, Dysthymia, Qvar, Ribavirin, Flovent, Budesonide, Entocort, Seasonal Affective Disorder, Tobramycin, Mometasone, Entocort EC, Chronic Obstructive Pulmonary Disease, Acute, Acetylcysteine, Beclomethasone, Mucomyst, Pulmicort Flexhaler

Kamada Wins FDA Approval for Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency

Posted 7 Jul 2010 by Drugs.com

NESS ZIONA, Israel--(BUSINESS WIRE)--Jul 6, 2010 - Kamada today announced that the United States Food and Drug Administration (FDA) has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin (AAT) for the treatment of Alpha 1 deficiency (AATD). Glassia is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market. The FDA approved Glassia following review of Kamada's Biological License Application (BLA) submitted in May 2009. The FDA's review included Kamada's clinical development as well as auditing and approving Kamada's manufacturing facility, quality assurance and controls. David Tsur, Chief Executive Officer of Kamada said, "We are very proud with this achievement. This success belongs to each one of the company's employees. With this unique product, Kamada is able to ... Read more

Related support groups: Alpha-1 Proteinase Inhibitor Deficiency, Alpha 1-Proteinase Inhibitor

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease

Related Drug Support Groups

Prolastin, Zemaira, Prolastin-C, Glassia, Aralast, alpha 1-proteinase inhibitor, Aralast NP